Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Polybrominated Diphenyl Ether Bromoxib Disrupts Nuclear Import and Export by Affecting Nucleoporins of the Nuclear Pore Complex.

Marine drugs·2025
Same author

Modelling of the multicellular tumor microenvironment of pancreatic ductal adenocarcinoma (PDAC) on a fit-for-purpose biochip for preclinical drug discovery.

Lab on a chip·2025
Same author

Incorporating immune cell surrogates into a full-thickness tissue equivalent of human skin to characterize dendritic cell activation.

Scientific reports·2024
Same author

MMW Fortschritte der Medizin·2024
Same author

Novel Histone Deacetylase (HDAC) Inhibitor Induces Apoptosis and Suppresses Invasion via E-Cadherin Upregulation in Pancreatic Ductal Adenocarcinoma (PDAC).

Pharmaceuticals (Basel, Switzerland)·2024
Same author

Indole Diketopiperazine Alkaloids from the Marine Sediment-Derived Fungus <i>Aspergillus chevalieri</i> against Pancreatic Ductal Adenocarcinoma.

Marine drugs·2024

Related Experiment Video

Updated: Jun 16, 2026

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells
09:51

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells

Published on: May 18, 2018

10.8K

Pseudopterosin A-D Modulates Dendritic Cell Activation in Skin Sensitization.

Johanna Maria Hölken1, Katja Friedrich1, Russel Kerr2

  • 1Institute of Pharmaceutical Biology and Biotechnology, Heinrich-Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany.

Marine Drugs
|June 25, 2025
PubMed
Summary
This summary is machine-generated.

Marine compounds pseudopterosin A-D (PsA-D) reduce nickel sulfate-induced skin sensitization by inhibiting inflammatory markers and cytokines. PsA-D shows promise as a therapeutic alternative to corticosteroids for allergic contact dermatitis.

Keywords:
Antillogorgia elisabethaeCD54CD86IL-8NF-kBNiSO4dermal dendritic cellsdexamethasonepseudopterosinskin

More Related Videos

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA

Published on: December 19, 2019

14.6K
A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
08:02

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

3.9K

Related Experiment Videos

Last Updated: Jun 16, 2026

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells
09:51

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells

Published on: May 18, 2018

10.8K
Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA

Published on: December 19, 2019

14.6K
A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
08:02

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

3.9K

Area of Science:

  • Marine natural products
  • Immunology
  • Dermatology

Background:

  • Nickel sulfate (NiSO4) is a common cause of allergic contact dermatitis.
  • Current treatments like corticosteroids have limitations.
  • Marine diterpene glycosides, such as pseudopterosin A-D (PsA-D), are being explored for their therapeutic potential.

Purpose of the Study:

  • To investigate the anti-inflammatory effects of PsA-D on NiSO4-induced skin sensitization.
  • To evaluate PsA-D's efficacy in preclinical models of skin sensitization.
  • To compare PsA-D's effectiveness with dexamethasone.

Main Methods:

  • Utilized dermal dendritic cell (DDC) surrogates to assess NiSO4-induced activation markers (CD54, CD86) and NF-κB pathway.
  • Measured pro-inflammatory cytokine secretion (IL-8, IL-6, IL-1β) in response to NiSO4 and PsA-D.
  • Employed a full-thickness human skin model to evaluate topical PsA-D's effect on NiSO4-induced mRNA expression of inflammatory mediators (IL-8, IL-6, IL-1β, COX-2, NLRP3).

Main Results:

  • PsA-D pre-treatment significantly reduced NiSO4-induced CD54 and CD86 upregulation in DDC surrogates.
  • PsA-D inhibited NiSO4-induced NF-κB activation by preventing IκBα degradation.
  • PsA-D suppressed the secretion of IL-8, IL-6, and IL-1β, and attenuated mRNA expression of these cytokines and mediators (COX-2, NLRP3) in human skin models.
  • PsA-D demonstrated comparable efficacy to dexamethasone.

Conclusions:

  • PsA-D exhibits significant anti-inflammatory effects against NiSO4-induced skin sensitization.
  • PsA-D acts by modulating key inflammatory pathways and cytokine production.
  • PsA-D represents a promising therapeutic alternative to corticosteroids for allergic contact dermatitis, warranting further research into formulation and bioavailability.